Sample question 1 · Technology and Security (20%)
Ridgemont Community Health Network, a mid-sized regional healthcare provider operating across four rural counties, has recently deployed an AI-assisted clinical decision support (CDS) tool integrated directly into its electronic health record (EHR) platform. The vendor's technology roadmap indicates the CDS tool will transition from a rule-based inference engine to a large language model (LLM)-based architecture within the next 18 months. During a routine risk review, the risk manager discovers that the current integration uses a legacy HL7 v2 messaging interface with no input validation controls, and that the planned LLM upgrade has not been assessed for algorithmic bias, data poisoning vulnerabilities, or HIPAA minimum necessary data principles. Clinical staff have already begun relying on the tool's recommendations for medication dosing. The organization's enterprise architecture team was not consulted during procurement. As the risk manager, which action should you prioritize FIRST to address the risk exposure introduced by the planned LLM-based upgrade to the clinical decision support tool?
- A. Require the vendor to delay the LLM upgrade until the organization completes a full HIPAA Security Rule compliance audit of the existing EHR platform.
- B. Conduct a structured risk assessment of the emerging LLM technology against the current threat landscape, including data poisoning, algorithmic bias, and PHI exposure vectors, and present findings to the risk owner before the upgrade proceeds.
- C. Implement input validation controls on the existing HL7 v2 interface immediately and treat the LLM upgrade as a separate project outside the current risk register.
- D. Escalate the procurement bypass to the compliance committee and recommend disciplinary action against the enterprise architecture team for failing to participate in the vendor selection process.
View answer & explanation
Correct answer: B. Conduct a structured risk assessment of the emerging LLM technology against the current threat landscape, including data poisoning, algorithmic bias, and PHI exposure vectors, and present findings to the risk owner before the upgrade proceeds.
[Domain 4 - Technology and Security, Subtopic 4A - Technology Principles - Area 8 - Emerging Technologies] Core Concept: Task 22 requires the risk practitioner to evaluate emerging technologies and environmental changes for threats, vulnerabilities, and opportunities before those changes are operationalized. Correct Answer (B): The LLM-based upgrade represents a material change in the technology environment with distinct risk characteristics - algorithmic bias, data poisoning, and PHI over-exposure - that differ fundamentally from the current rule-based system. The correct first action is to conduct a structured risk assessment of the emerging technology against the current threat landscape and present findings to the risk owner, enabling informed risk treatment decisions before the upgrade proceeds Why the other options are incorrect: Option A: A HIPAA audit of the existing platform does not address the forward-looking risks of the new LLM architecture. Option C: Is partially valid (fixing the HL7 gap is warranted) but treating the LLM upgrade as a separate, out-of-scope item ignores the risk manager's obligation to evaluate emerging technology changes proactively. Option D: Conflates a governance process failure with a risk management response; escalating a procurement issue does not address the substantive technology risk and is not the highest-priority action.